NCT00821795View on ClinicalTrials.gov

Veterans Inpatient Insulin Study and Transition to Outpatient Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 11, 2009

Primary Completion Date

April 23, 2013

Study Completion Date

April 23, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

NPH/Regular 70/30 mix

injectable solution, subcutaneous,0.3-0.5 units/kg/day divided into twice per day dosage, 16 weeks duration

DRUG

insulin aspart protamine/insulin aspart 70/30 mix

injectable solution, subcutaneous, 0.3-0.5 units/kg/day divided into twice per day dosage, for 16 weeks

Trial Locations (1)

40502

VA Medical Center - Lexington 596, Lexington

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Dennis G. Karounos, M.D.

FED